This webinar will feature leading experts and patient voices who will delve into the scientific, clinical, and human aspects of desensitisation. Attendees will gain a comprehensive understanding of HLA sensitisation, learn to identify which patients could benefit from desensitisation protocols, and hear firsthand experiences of patients navigating this complex journey.
A unique dialogue between a patient and a nurse will provide an authentic perspective on the impact of desensitisation on patient care and outcomes, offering valuable insights for healthcare professionals and patient communities alike.
Who Should Attend?
This session is tailored for a wide audience, including:
- Transplant patients, their families, and caregivers
- Patient representatives
- Nurses
- Physicians
- Scientists
- Allied healthcare professionals
Key Learning Objectives:
- Understand the immunological basis of sensitisation and desensitisation in kidney transplantation, with a focus on HLA compatibility.
- Identify which patients may benefit from desensitisation protocols, evaluating the principles, indications, and associated risks.
- Recognise the patient journey, gaining insights into the challenges faced and how healthcare professionals can enhance support and care.
Programme Highlights:
- Welcome – Xavier Charmetant
- HLA and Immunological Perspective – Alice Koenig
- Eligibility and Risks of Desensitisation – Annelies de Weerd
- Q&A with the Full Panel
- Patient Perspective: A Dialogue – Marleen van Buren and Mr. Sanchez
- Wrap-up and Closing Remarks – Marleen van Buren
This activity is made possible by unrestricted grants from HANSA Biopharma.
Mark your calendar and register to participate in this important discussion designed to empower patients, caregivers, and healthcare professionals.
